Elastrin Therapeutics

Elastrin Therapeutics

Biotechnology Research

Oxford, England 2,360 followers

Using drug-loaded nanoparticles for the effective treatment of life-threatening diseases

About us

Elastrin Therapeutics is a UK and US-based biotech developing novel therapies to reverse cardiovascular disease. Its underlying technology was developed by Dr. Naren Vyavahare during the last 20 years at Clemson University, in collaboration with Dr. Charles Rice. Our team built a proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries.

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Oxford, England
Type
Privately Held
Founded
2017
Specialties
Biotechnology, Biotech, cardiovascular diseases, drug discovery, and elastrin

Locations

  • Primary

    Robert Robinson Avenue

    John Eccles House

    Oxford, England OX4 4GP, GB

    Get directions
  • 200c Patewood Dr

    Greenville, South Carolina 29615, US

    Get directions

Employees at Elastrin Therapeutics

Updates

Similar pages

Browse jobs

Funding

Elastrin Therapeutics 4 total rounds

Last Round

Series unknown

US$ 4.8M

See more info on crunchbase